| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.23B | 34.00B | 32.15B | 9.60B | 9.58B | 9.34B |
| Gross Profit | 12.95B | 10.44B | 13.64B | 9.60B | 13.27B | 9.34B |
| EBITDA | 6.56B | 6.59B | 6.90B | 0.00 | 6.69B | 6.44B |
| Net Income | 5.79B | 5.51B | 5.12B | 4.93B | 4.87B | 4.66B |
Balance Sheet | ||||||
| Total Assets | 1.10T | 1.03T | 856.64B | 759.88B | 684.71B | 618.95B |
| Cash, Cash Equivalents and Short-Term Investments | 71.52B | 145.40B | 63.40B | 55.74B | 48.52B | 44.39B |
| Total Debt | 420.47B | 400.78B | 194.99B | 156.41B | 136.13B | 120.60B |
| Total Liabilities | 1.04T | 976.52B | 792.88B | 700.58B | 633.22B | 569.71B |
| Stockholders Equity | 59.24B | 54.92B | 61.07B | 56.92B | 49.34B | 47.27B |
Cash Flow | ||||||
| Free Cash Flow | 89.67B | 95.15B | -21.42B | 4.03B | 4.97B | 4.74B |
| Operating Cash Flow | 90.98B | 96.43B | -20.75B | 4.45B | 5.31B | 5.09B |
| Investing Cash Flow | -163.38B | -52.33B | -14.50B | -20.98B | -12.89B | -15.84B |
| Financing Cash Flow | 111.72B | 6.52B | 32.21B | 16.32B | 9.94B | 16.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$39.50B | 3.55 | 9.70% | 5.69% | 11.27% | 12.75% | |
71 Outperform | HK$86.49B | 4.35 | 9.19% | 5.16% | -1.33% | 7.09% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | HK$33.54B | 3.69 | 12.90% | 4.45% | ― | ― | |
60 Neutral | HK$13.84B | 1.84 | 5.25% | 6.13% | -3.62% | 1.69% | |
56 Neutral | HK$24.87B | 4.55 | 6.51% | 7.99% | -8.83% | -16.92% | |
50 Neutral | HK$13.90B | 5.08 | 0.67% | ― | -6.29% | -6.68% |